D-0275-2022 Class III Terminated
FDA drug recall D-0275-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Jun 23, 2023). Affected quantity: 2,928 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 15, 2021
- Initiation Date
- Nov 12, 2021
- Termination Date
- Jun 23, 2023
- Product Quantity
- 2,928 cartons
Product description
Fexofenadine HCl, 60 mg & Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy and Congestion, 30 Tablets, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ, 08640, Made in India NDC Walmart Inc., Bentonville, AR 72716, Product of India, NDC 43598-823-31.
Reason for recall
Failed dissolution specifications
Distribution pattern
USA Nationwide.
Code information
Lot #: AC2103329A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0275-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026